Methods for treating or preventing cancers involving the administration of anti-ccr5 receptor agents
WO2020206026A1
Anti-ccr5 agents and methods of treatment that block cancer metastasis or enhance cell death induced by dna damaging chemotherapy
WO2019055995A1
Screening methods for identifying and treating hiv-1 infected patient sub-populations suitable for long term anti-ccr5 agent therapy
CN110831436A
Humanized mouse model
WO2018209301A1
Methods for treating or preventing graft-versus-host disease involving the administration of anti-ccr5 receptor agents
CA2988650A1
Inhibition of ccl5 ligand binding to ccr5 receptor and alteration of ccr5/ccl5 axis signaling in inflammation, cancer, autoimmune, and other conditions
AU2015305401A1
HIV antibody therapy as treatment substitute
WO2015126892A1
Use of anti-ccr5 antibodies in graft versus host disease
EP2983711A1
Felinized antibodies and methods of treating retroviral infections in felines
US2013216526A1
Methods for reducing viral load in HIV-1 infected patients
WO2013040188A1
Anti-cd11a antibodies and uses thereof
WO2012174392A1
Methods of treating retroviral infections in felines
AU2011223805A1
Concentrated protein formulations and uses thereof
